Ventas, Inc. (NYSE:VTR) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Key Points

• Analysts hold a consensus “Moderate Buy” rating on Ventas, with 15 buy ratings and three holds among 18 analysts. The average 12-month price target is $98.00, modestly above the reported $93.47 share price.
• Ventas beat quarterly expectations, reporting $0.97 EPS versus a $0.96 consensus estimate and $1.73 billion in revenue versus $1.68 billion expected. Revenue increased 21.7% year over year.
• The healthcare-focused REIT has attracted substantial institutional ownership, with institutions holding 94.18% of outstanding shares; a company director also purchased 2,500 shares in June.

Ventas, Inc. (NYSE:VTR - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eighteen analysts that are presently covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $98.00.

VTR has been the subject of a number of analyst reports. Scotiabank cut their price objective on Ventas from $95.00 to $88.00 and set a "sector perform" rating for the company in a report on Thursday, June 18th. JPMorgan Chase & Co. upped their target price on shares of Ventas from $93.00 to $94.00 and gave the stock an "overweight" rating in a report on Monday, May 11th. Citigroup increased their target price on shares of Ventas from $100.00 to $110.00 and gave the stock a "buy" rating in a research report on Tuesday, August 4th. Royal Bank Of Canada lifted their price target on shares of Ventas from $98.00 to $99.00 and gave the company an "outperform" rating in a report on Friday, August 14th. Finally, UBS Group boosted their price target on shares of Ventas from $85.00 to $93.00 and gave the company a "neutral" rating in a research report on Monday, May 4th.

Ventas Price Performance

Ventas stock opened at $93.47 on Tuesday. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44. The company has a market capitalization of $47.94 billion, a PE ratio of 173.09, a price-to-earnings-growth ratio of 2.15 and a beta of 0.69. Ventas has a one year low of $66.38 and a one year high of $101.60. The business has a 50 day simple moving average of $91.56 and a 200 day simple moving average of $87.26.

Ventas (NYSE:VTR - Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 EPS for the quarter, beating the consensus estimate of $0.96 by $0.01. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The business had revenue of $1.73 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the previous year, the firm earned $0.87 EPS. Ventas's quarterly revenue was up 21.7% on a year-over-year basis. On average, sell-side analysts forecast that Ventas will post 3.89 EPS for the current fiscal year.

Insider Buying and Selling at Ventas

In other news, Director Michael J. Embler bought 2,500 shares of the business's stock in a transaction dated Wednesday, June 3rd. The stock was bought at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the purchase, the director owned 19,202 shares of the company's stock, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.53% of the company's stock.

Institutional Investors Weigh In On Ventas

A number of large investors have recently bought and sold shares of VTR. Dynamic Wealth Strategies LLC acquired a new position in Ventas in the first quarter worth $25,000. Silvant Capital Management LLC bought a new stake in shares of Ventas during the second quarter worth $28,000. Meeder Asset Management Inc. acquired a new stake in shares of Ventas in the second quarter valued at $30,000. Wiser Advisor Group LLC acquired a new stake in shares of Ventas in the third quarter valued at $27,000. Finally, IFC & Insurance Marketing Inc. bought a new position in shares of Ventas in the fourth quarter valued at about $30,000. 94.18% of the stock is currently owned by institutional investors.

About Ventas

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source